See more : Zhejiang Shibao Company Limited (1057.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Jiutian Chemical Group Limited (C8R.SI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jiutian Chemical Group Limited, a leading company in the Chemicals industry within the Basic Materials sector.
- Workday, Inc. (0M18.L) Income Statement Analysis – Financial Results
- Axiata Group Berhad (6888.KL) Income Statement Analysis – Financial Results
- Cannabotech LTD (CNTC.TA) Income Statement Analysis – Financial Results
- Allup Silica Limited (APS.AX) Income Statement Analysis – Financial Results
- Chong Hing Bank Limited (1111.HK) Income Statement Analysis – Financial Results
Jiutian Chemical Group Limited (C8R.SI)
About Jiutian Chemical Group Limited
Jiutian Chemical Group Limited, an investment holding company, manufactures and sells chemical-based products in the People's Republic of China. The company offers dimethylformamide, which is used as a feedstock in the production of polyurethane, pharmaceutical, and agro chemical products, as well as an absorbing agent primarily in electronics, acrylic fibers, and pharmaceutical products; and methylamine, a chemical feedstock in the organic chemical industry used in various areas, such as agricultural chemicals, medicines, fuels, synthetic resins, and leather making, as well as in the production of the solvent used for chemical fibers, activating agents, and photography. It also provides sodium hydrosulfite, a crystalline powder for use in water treatment, gas purification, cleaning, and stripping, as well as in the industrial processing of textiles, leather, foods, polymers, photography, and others; industrial and consumable carbon dioxide for use in aerated beverages, tobacco, and preserving vegetables; Oxygen-18, an isotope of oxygen to produce fluorodeoxyglucose; deuterium depleted water to inhibit cancer growth; and industrial methanol. In addition, the company is involved in the sale of downstream products; and research and development of isotope technology. Jiutian Chemical Group Limited was founded in 1994 and is based in Singapore.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 598.56M | 2.43B | 2.17B | 1.15B | 1.05B | 1.31B | 1.12B | 708.51M | 677.98M | 934.11M | 970.79M | 918.04M | 828.79M | 462.43M | 216.53M | 252.49M | 301.67M | 236.77M | 188.22M |
| Cost of Revenue | 858.74M | 1.73B | 1.50B | 871.48M | 979.57M | 1.18B | 976.24M | 669.08M | 663.89M | 876.75M | 912.65M | 885.28M | 881.70M | 552.37M | 273.48M | 220.31M | 200.20M | 151.35M | 135.25M |
| Gross Profit | -260.18M | 708.41M | 675.62M | 274.77M | 74.89M | 132.65M | 148.20M | 39.44M | 14.10M | 57.36M | 58.14M | 32.75M | -52.91M | -89.94M | -56.95M | 32.18M | 101.46M | 85.42M | 52.97M |
| Gross Profit Ratio | -43.47% | 29.09% | 31.09% | 23.97% | 7.10% | 10.14% | 13.18% | 5.57% | 2.08% | 6.14% | 5.99% | 3.57% | -6.38% | -19.45% | -26.30% | 12.74% | 33.63% | 36.08% | 28.14% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 37.56M | 44.01M | 41.13M | 21.57M | 23.62M | 26.42M | 26.85M | 24.62M | 26.55M | 23.85M | 26.37M | 24.13M | 28.80M | 22.46M | 33.80M | 37.07M | 23.35M | 16.16M | 9.19M |
| Selling & Marketing | 11.53M | 18.75M | 17.76M | 14.02M | 22.67M | 20.90M | 19.58M | 16.87M | 12.06M | 16.05M | 25.06M | 20.68M | 2.06M | 1.73M | 1.23M | 1.10M | 2.31M | 448.00K | 389.00K |
| SG&A | 49.09M | 62.76M | 58.89M | 35.59M | 46.29M | 47.33M | 46.43M | 41.50M | 38.61M | 39.90M | 51.43M | 44.81M | 30.86M | 24.18M | 35.03M | 38.17M | 25.66M | 16.60M | 9.58M |
| Other Expenses | -30.00K | 1.61M | 576.00K | 20.00K | 1.27M | 1.22M | 2.09M | 1.51M | 1.49M | 2.21M | 2.13M | 2.00M | 3.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | -260.18M | 62.23M | 58.81M | 33.96M | 46.29M | 47.33M | 46.43M | 34.45M | 36.39M | 37.69M | 42.38M | 37.50M | 19.24M | -1.90M | 35.35M | 37.71M | 20.89M | 16.60M | 9.58M |
| Cost & Expenses | 598.56M | 1.79B | 1.56B | 905.45M | 1.03B | 1.22B | 1.02B | 703.53M | 700.28M | 914.44M | 955.03M | 922.78M | 900.94M | 550.47M | 308.83M | 258.02M | 221.10M | 167.95M | 144.83M |
| Interest Income | 15.36M | 15.03M | 5.10M | 3.61M | 2.19M | 1.64M | 332.00K | 957.00K | 2.09M | 1.08M | 2.52M | 3.15M | 1.12M | 0.00 | 554.00K | 1.14M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.98M | 2.30M | 3.67M | 5.75M | 5.84M | 5.40M | 5.38M | 4.84M | 1.96M | 0.00 | 0.00 | 226.00K | 4.01M | 4.17M | 8.87M | 13.29M | 5.08M | 2.94M | 0.00 |
| Depreciation & Amortization | 23.18M | 22.31M | 28.98M | 26.47M | 27.83M | 29.08M | 31.35M | 29.67M | 29.11M | 31.39M | 28.38M | 27.61M | 28.47M | 33.69M | 39.83M | 38.64M | 16.41M | 9.19M | 7.87M |
| EBITDA | -321.76M | 696.61M | 632.38M | 259.93M | -235.69M | 69.69M | 127.15M | 34.77M | 21.14M | 51.97M | 49.76M | 29.40M | -50.35M | -56.21M | -51.91M | 33.10M | 96.98M | 78.01M | 51.26M |
| EBITDA Ratio | -53.76% | 28.88% | 29.10% | 22.68% | -8.45% | 5.26% | 11.45% | 4.96% | 3.08% | 5.56% | 5.13% | 3.31% | -6.07% | -12.15% | -23.98% | 13.11% | 32.15% | 32.95% | 27.23% |
| Operating Income | -309.23M | 680.84M | 603.40M | 233.46M | -116.96M | 39.76M | 97.38M | 5.46M | -8.23M | 20.57M | 21.39M | 2.80M | -78.82M | -89.90M | -91.74M | -5.54M | 80.57M | 68.82M | 43.39M |
| Operating Income Ratio | -51.66% | 27.96% | 27.76% | 20.37% | -11.09% | 3.04% | 8.66% | 0.77% | -1.21% | 2.20% | 2.20% | 0.31% | -9.51% | -19.44% | -42.37% | -2.19% | 26.71% | 29.07% | 23.05% |
| Total Other Income/Expenses | -37.69M | -8.85M | -131.67M | 1.63M | -297.95M | -4.55M | -11.36M | -5.20M | 13.09M | 7.29M | -147.00K | 6.60M | -13.01M | -72.03M | -8.87M | -39.15M | -5.08M | -2.94M | -2.31M |
| Income Before Tax | -346.92M | 671.99M | 485.15M | 242.43M | -269.35M | 35.21M | 90.42M | 261.00K | -9.21M | 27.86M | 21.24M | 1.57M | -91.82M | -160.07M | -100.62M | -45.83M | 75.49M | 67.33M | 41.08M |
| Income Before Tax Ratio | -57.96% | 27.60% | 22.32% | 21.15% | -25.54% | 2.69% | 8.04% | 0.04% | -1.36% | 2.98% | 2.19% | 0.17% | -11.08% | -34.61% | -46.47% | -18.15% | 25.02% | 28.43% | 21.82% |
| Income Tax Expense | -195.00K | 181.62M | 160.66M | 69.31M | 9.54M | 14.26M | 20.34M | -98.00K | -778.00K | 844.00K | 0.00 | 25.00K | -172.00K | -2.92M | -2.18M | 8.18M | 15.24M | -321.00K | -278.00K |
| Net Income | -344.64M | 490.50M | 324.90M | 173.69M | -248.42M | 22.08M | 70.82M | 586.00K | -8.72M | 27.01M | 21.24M | 1.32M | -90.79M | -155.32M | -95.71M | -50.82M | 61.29M | 67.65M | 41.35M |
| Net Income Ratio | -57.58% | 20.14% | 14.95% | 15.15% | -23.56% | 1.69% | 6.30% | 0.08% | -1.29% | 2.89% | 2.19% | 0.14% | -10.95% | -33.59% | -44.20% | -20.13% | 20.32% | 28.57% | 21.97% |
| EPS | -0.17 | 0.25 | 0.16 | 0.09 | -0.14 | 0.01 | 0.04 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | -0.05 | -0.09 | -0.06 | -0.03 | 0.05 | 0.06 | 0.04 |
| EPS Diluted | -0.17 | 0.25 | 0.16 | 0.09 | -0.14 | 0.01 | 0.04 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | -0.05 | -0.09 | -0.06 | -0.03 | 0.05 | 0.06 | 0.04 |
| Weighted Avg Shares Out | 1.99B | 1.99B | 1.99B | 1.85B | 1.82B | 1.82B | 1.82B | 1.82B | 1.82B | 1.82B | 1.80B | 1.66B | 1.66B | 1.66B | 1.66B | 1.53B | 1.36B | 1.08B | 1.08B |
| Weighted Avg Shares Out (Dil) | 1.99B | 1.99B | 1.99B | 1.85B | 1.82B | 1.82B | 1.82B | 1.82B | 1.82B | 1.82B | 1.80B | 1.66B | 1.66B | 1.66B | 1.66B | 1.53B | 1.36B | 1.08B | 1.08B |
Source: https://incomestatements.info
Category: Stock Reports